In the PPI network of gene targets of DSD for the treatment of MI, TP53 (p53), EGFR, AKT1, STAT3, IL6, IL1B, SRC, and MYC are in central positions, indicating that they may be key targets for MI treatment. Here, TP53 is linked to disorder of sexual differentiation.